title: Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.
authors.forename: J Martin
authors.initials: JM
authors.lastname: Brown
authors.forename: David J
authors.initials: DJ
authors.lastname: Brenner
authors.forename: David J
authors.initials: DJ
authors.lastname: Carlson
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000601:surgery*; D019583:Dose Fractionation, Radiation; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery*; D059351:Organ Sparing Treatments / Q000379:methods; D011836:Radiation Tolerance; D016634:Radiosurgery / Q000379:methods*; D016896:Treatment Outcome